Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

Minimal residual disease evaluation refers to a series of molecular and immunophenotypical techniques aimed at detecting submicroscopic disease after therapy. As such, its application in acute myeloid leukemia has greatly increased our ability to quantify treatment response, and to determine the che...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosna, Federico, Capelli, Debora, Gottardi, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483867/
https://www.ncbi.nlm.nih.gov/pubmed/28587190
http://dx.doi.org/10.3390/jcm6060057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483867/
https://www.ncbi.nlm.nih.gov/pubmed/28587190
http://dx.doi.org/10.3390/jcm6060057

Ejemplares similares